Tennessee Oncology Promotes Arrowsmith, Blakeley, Chollet Lipscomb Into New Leadership Roles

Author(s):

Tennessee Oncology, a nationally recognized independent oncology practice with 35 clinics across Tennessee and Northwest Georgia, announced today new roles for three physician executive leaders.

Johnetta Blakely, MD, MS, MMHC

Johnetta Blakely, MD, MS, MMHC; Casey Chollet Lipscomb, MD, and Edward R. "Ted" Arrowsmith, MD, MPH, have been promoted to Executive Vice President of Quality and Clinical Operations, Physician Services, and Therapeutics,

Casey Chollet Lipscomb MD

respectively. All 3 physicians are currently on Tennessee Oncology’s board of directors and are practicing physicians. Blakely practices in Cookeville, Chollet Lipscomb practices in Nashville, and Arrowsmith treats patients in Chattanooga.

Edward R. "Ted" Arrowsmith | All Images: Tennessee Oncology

“Each of these oncologists are world-class physicians and leaders who will help take Tennessee Oncology to the next level,” said Natalie Dickson, MD, president and chief strategy officer. “I am excited to work alongside my colleagues to build on Tennessee Oncology’s proud history and continue bringing the highest quality of cancer care and innovative therapies to Tennessee patients. Caring for cancer patients is indeed a privilege, and I’m looking forward to contributions of each of my colleagues.”

Blakely attended the University of Tennessee’s medical school. She completed her fellowship in hematology/oncology at MD Anderson Cancer Center, holds a master’s degree in clinical research from MD Anderson as well as a master’s degree in healthcare management from Vanderbilt. Chollet Lipscomb attended medical school at University of Tennessee, conducted her residency at Loyola University Medical Center in Chicago, and was an attending at Duke University prior to joining Tennessee Oncology. Arrowsmith’s medical degree and fellowship are both from Vanderbilt University. He is also the head of pathway development at OneOncology, the fastest growing national platform for independent oncology practices.